Franklin Street Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Franklin Street Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,325	Closed	-$924K	–	242
2015 Q3	$924K	Hold	12,325	–	–	0.18%	118
2015 Q2	$928K	Buy	+12,325	New	+$660K	0.17%	123

Franklin Street Advisors's KYTH Position: Q4 2015 in Review

Franklin Street Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 12,325 shares — an estimated $924K sold.

Franklin Street Advisors first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $928K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Franklin Street Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Franklin Street Advisors sold 12,325 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $924K.
Franklin Street Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
Franklin Street Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $928K in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Franklin Street Advisors's 13F filing for Q4 2015, filed 14 Jan 2016.